“Growing Demand for Azithromycin in Respiratory Infections”
A significant trend driving the growth of the azithromycin market is the increasing demand for the drug in treating respiratory infections, especially in the context of the COVID-19 pandemic. Azithromycin has been widely prescribed for bacterial respiratory infections, and its use in combination with other drugs has gained popularity for treating severe cases of pneumonia and bronchitis. The growing prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, has further boosted the demand for azithromycin. For instance, in 2023, the demand for azithromycin surged in regions such as Europe and North America due to rising respiratory conditions, contributing to market expansion.
